PATENT CLAIM ANALYSIS

Application Number: 15872307
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "252200"]

Abstract:
The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.

Claim (Index 1):
A method for treating or preventing a FGFR3-related skeletal disease which comprises the step of administering at least one antagonist of the FGFR3 tyrosine kinase receptor of formula: or a composition comprising such an antagonist, to a subject in need thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.28947
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14844041', '10734661', '12394756', '12350940', '12731100']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6980489733471436
- 35 USC 102 Novelty (BERT): 0.6149114629545411
- Combined Prediction Score: 0.6897352223078834
- Mean Citation Score: 261.66312
- Max Citation Score: 548.14777
- Similarity Product: 516.3712912902297

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test